| |
The Journal
of Investigational Allergology & Clinical
Immunology will consider for publication
those papers directly related to allergology
and clinical and experimental
immunopathology.
The journal subscribes to the Uniform
Requirements for Manuscripts Submitted to
Biomedical Journals (henceforth the Uniform
Requirements) of the International Committee
of Medical Journal Editors (ICMJE):
http://www.icmje.org . Further
specifications follow.
The Journal will
comprise the following major sections:
Original Articles. Original research
papers in allergy and
immunopathology, new forms of therapy
for allergic and immune
disorders, new applications of
diagnostic methods, and clinical and
experimental studies on the
immunopathogenesis of allergic diseases
and
immune disorders are welcome. Note that
a report of a case series may
be considered an original article only
if there is an explicit objective that
motivated the retrospective or
prospective (cohort) study, which should
include appropriate statistical
treatment of the data.
Advice on appropriate sectioning of
original articles can be found
in the ICMJE’s Uniform Requirements. In
those requirements, it is also
recommended that certain study designs
follow particular structures for
optimum reporting. Links to those
specifi c recommendations can be
obtained from the ICMJE website. They
are the CONSORT statement
for randomized controlled trials, the
STARD statement for studies of
diagnostic accuracy, the QUOROM
statement for systematic reviews
and meta-analyses of trials, the STROBE
statement for observational
studies, and the MOOSE statement for
systematic analyses and metaanalyses of
observational studies.
Practitioner’s Corner. These short
papers, which are intended for
rapid publication, follow the same
structures as longer original articles
described above but do not use
subheadings or include an abstract. The
text is strictly limited to less than
1000 words (please supply a word
count), up to 10 references, 1 fi gure
or table, and up to 5 key words.
Editorials and Review Articles.
Contributions from specialists in the
fi eld are requested by the Editors.
Unsolicited reviews will be subject
to consideration by the Editorial Board
or subject to peer review at the
Board’s discretion.
Letters
to the Editor. Comments on articles
published in J Investig
Allergol Clin Immunol are welcome. The
letter will be sent to the author
of the related article, who will have 4
weeks to answer. After the reply,
no further correspondence will be
accepted. Letters will be reviewed by
the Editorial Board or subject to peer
review at the Board’s discretion.
Submission
of Manuscripts
Manuscripts can
be submitted as a Microsoft Word file or a
rich text format (RTF) fi le at the website:
http://recyt.fecyt.es/index.php/JIACI/index
. File names should include the
corresponding author’s surname.
Each figure should be in a separate document,
and the file name for each should include
the corresponding author’s surname and a key
word that indicates the fi gure number and
manuscript it pertains to.
Author
Assurances. A cover letter requesting
review by the Editorial Board for
publication in the journal should accompany
the manuscript and include a statement by
the authors(s) confi rming that the
manuscript has not been published elsewhere
and is not under consideration for
publication elsewhere, as well as a
statement of consent from all the authors.
Conflicts of interest. Authors must
disclose any fi nancial or personal
relationship which could result in a confl
ict of interest with regard to the published
article. Even if the authors consider that
there is none, they must declare it.
All manuscripts accepted for publication
remain the property of theJ Investig
Allergol Clin Immunol and are subject to
copyright restrictions regarding
reproduction. Manuscripts published in or
submitted to another journal cannot be
considered.
Preparation
of Manuscripts
Manuscripts should be typewritten, double-spaced
with ample margins on all sides, and with
numbered pages, following the ICMJE Uniform
Requirements. The word limits for the body
of the text, not including abstract, figure
legends, or references are as follows:
original articles, 3500 words; reviews 5000
(exceptionally up to 7500 words could
be accepted); short communications, brief
case notes and letters, 1000. (Please supply
a word count on the title page.)
Title
Page. The first page should contain
the full title, a brief running title
(not to exceed 40 characters), full name
of author(s), institutional affi liation
of author(s), and name, mailing address,
fax and e-mail of the author to
whom all correspondence should be
directed. Note the word count and the
number of tables and fi gures. If data
have been presented in abstract or
poster form at conferences, this
information should be noted after the
title page, as should funding sources
for the study or any author conflicts of
interest.
Abstract. Original articles, and
reviews require abstracts. The major
points of the article should be
summarized in to 250 words (original
and review articles), in the order of
their appearance in the manuscript.
Material or facts not cited in the full
manuscript should not be included in
the abstract. The abstract of an
original article should be organized
with the
following subheadings: Background (optional),
Objective(s), Methods (or
Material and Methods or Patients and
Methods, as appropriate), Results,
Conclusion(s). Such structuring is
unnecessary for reviews.
Key Words. Three to 8 key words or brief
phrases should be
included after the abstract for indexing
purposes. The Medical Subject
Headings used by the US National Library
of Medicine’s Index Medicus
(MEDLINE) are preferred.
Main Text. For original articles,
authors should follow the ICMJE
Uniform Requirements for structuring
their articles into sections and
subsections, as mentioned above.
Tables. Each table should be typed
on a separate page after the
references. Authors are requested,
whenever possible, to construct tables
that can be arranged on the page and
read in the same direction as the
text. Titles should not exceed 2 lines.
Information appearing in fi gures or
text should not be included in tables.
Figures. Figures should illustrate
important results, and they should
be cited in the text. Line artwork (such
as graphs) should be submitted as
TIFF files, with a minimum resolution of
800 dpi. Other artwork (such as
photographs) should be submitted as
250-300 dpi TIFF fi les. Legends should
be included on a separate page in the
manuscript, after the references.
Acknowledgments. When necessary,
credit should be given to
persons, centers, or foundations that
have collaborated in the study.
Please also acknowledge help received in
preparation of the manuscript
(editing services, translation, or other)
or statistical analysis. Refer to
advice in the ICMJE’s Uniform
Requirements.
References. All references should be
numbered consecutively
throughout the text and enclosed in
square brackets placed before
punctuation. Journal abbreviations in
the reference list should be those
of the US National Library of Medicine’s
Index Medicus. (See a few
examples below.) Complete citation of
all the author(s) name(s) should
be followed by the complete title of the
paper, abbreviated journal title,
year, volume, and fi rst and last page
number. When citing a chapter from
a book, the author(s) name(s) should be
followed by the complete title of
the paper, title of the book, volume
number, editor(s) name(s), address and
name of the publisher, year, and fi rst
and last page numbers: References
(with the exception of review articles)
should be limited to approximately
35 for original articles and
approximately 10 for the Practitioner’s
Corner.
Authors should not submit manuscripts in
which Microsoft Word
footnoting tools have been used to
insert references; if other reference
management software is used, authors
should remove the hyperlinks
before submitting the manuscript.
Following are 3 examples of reference
presentation forms. For
additional examples, see the US National
Library of Medicine’s complete
list:
http://www.nlm.nih.gov/bsd/uniform_requirements.html
.
1. Parameswaran K, Radford K, Zuo J,
Janssen LJ, O’Byrne PM,
Cox PG. Extracellular matrix regulates
human airway smooth
muscle cell migration. Eur Respir J.
2004;24:545-51.
2. Global Initiative for Asthma. Global
Strategy for Asthma
Management and Prevention NIH Pub. No
02-3659, January
1995. Updated 2005. [cited 2006 Oct 24].
Available from: www.
ginasthma.com.
3. Marsh DG. Genetic and molecular
analysis of human immune
responsiveness to allergens. In: Marsh
DG, Lockhart A,
Holgate ST, editors. The genetics of
asthma. Oxford: Blackwell
Scientifi c Publications; 1993. p.
201-13.
Copyediting and Proofreading
The corresponding author will be contacted
by a copyeditor while the manuscript is
being prepared for publication, so that the
author can approve any modifi cations
suggested. Furthermore, the corresponding
author will receive the copyedited
manuscript by e-mail with proposed
modifications marked on the fi le, for
approval or correction. This process
should ensure that the manuscript is both
correct and readable, to the author’s
satisfaction. If the author is unavailable
during this process, publication delay may
result.
A minimal number of changes should be
necessary on page proofs, which will be sent
to the same corresponding author a few weeks
later.
Proofs, particularly tables and fi gures,
should be checked against the original
manuscript. Authors will be charged for
major alterations in the original text, so
attention should be given during the
copyediting phase. Proofs not returned in
time to meet the publication date will
either be rescheduled or published without
the authors’ corrections, in which case the
Editors do not assume responsibility for any
errors that might have been made in
typesetting. |
